Ik-hwan S. Han
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Trichomonas vaginalis-induced inflammation is associated with Th17 differentiation and tumor-intrinsic IL-17R signaling in prostate cancer progression.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: March 18, 2026
Melittin Reprograms Tumor-Associated Macrophages Through CD18-Mediated Immunomodulation.
Journal: Phytotherapy research : PTR
Published: March 05, 2026
CD18-targeted peptide-drug conjugate remodels the immunosuppressive tumor microenvironment of prostate cancer by selective depletion of M2 macrophages.
Journal: NPJ precision oncology
Published: November 25, 2025
STAT6 inhibition of M2 macrophages suppresses tumor growth by modulating the tumor microenvironment in colon cancer model.
Journal: Frontiers in immunology
Published: October 28, 2025
The CD300c antibody CL7 suppresses tumor growth by regulating the tumor microenvironment in non-small cell lung carcinoma.
Journal: Frontiers in oncology
Published: September 04, 2025
Immunomodulatory peptide-drug conjugate MEL-dKLA suppresses progression of prostate cancer by eliminating M2-like tumor-associated macrophages.
Journal: Frontiers in immunology
Published: June 23, 2025
The Combination of CD300c Antibody with PD-1 Blockade Suppresses Tumor Growth and Metastasis by Remodeling the Tumor Microenvironment in Triple-Negative Breast Cancer.
Journal: International journal of molecular sciences
Published: April 20, 2025
Conformation-sensitive targeting of CD18 depletes M2-like tumor-associated macrophages resulting in inhibition of solid tumor progression.
Journal: Journal for immunotherapy of cancer
Published: March 23, 2025
Therapeutic effects of MEL-dKLA by targeting M2 macrophages in pulmonary fibrosis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 17, 2024
Melittin derived peptide-drug conjugate, M-DM1, inhibits tumor progression and induces effector cell infiltration in melanoma by targeting M2 tumor-associated macrophages.
Journal: Frontiers in immunology
Published: March 03, 2023
Inflammatory response to Trichomonas vaginalis in the pathogenesis of prostatitis and benign prostatic hyperplasia.
Journal: Parasites, hosts and diseases
Published: November 23, 2022
Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer.
Journal: International journal of molecular sciences
Published: November 11, 2022
Last Updated: 09/26/2026